ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Fusen Pharmaceutical Co., Ltd. ?
Unrated Stock - No Analysis Available
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-12.52%
EBIT Growth (5y)
-206.03%
EBIT to Interest (avg)
3.07
Debt to EBITDA (avg)
2.34
Net Debt to Equity (avg)
1.06
Sales to Capital Employed (avg)
0.49
Tax Ratio
1.90%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
5.65%
ROE (avg)
3.42%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.34
EV to EBIT
-17.79
EV to EBITDA
-61.17
EV to Capital Employed
1.73
EV to Sales
4.62
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-9.72%
ROE (Latest)
-49.94%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend15What is working for the Company
OPERATING CASH FLOW(Y)
Highest at HKD 282.13 MM
ROCE(HY)
Highest at -3.13%
CASH AND EQV(HY)
Highest at HKD 93.39 MM
NET SALES(Q)
At HKD 177.44 MM has Grown at 26.1%
PRE-TAX PROFIT(Q)
Highest at HKD 6.52 MM
NET PROFIT(Q)
Highest at HKD 12.43 MM
EPS(Q)
Highest at HKD 0.02
-2What is not working for the Company
RAW MATERIAL COST(Y)
Grown by 34.51% (YoY
INTEREST(Q)
Highest at HKD 13.09 MM
Here's what is working for Fusen Pharmaceutical Co., Ltd.
Pre-Tax Profit
At HKD 6.52 MM has Grown at 114.15%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (HKD MM)
Net Profit
At HKD 12.43 MM has Grown at 107.54%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very positive
Net Profit (HKD MM)
Operating Cash Flow
Highest at HKD 282.13 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (HKD MM)
Net Sales
At HKD 177.44 MM has Grown at 26.1%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (HKD MM)
Pre-Tax Profit
Highest at HKD 6.52 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (HKD MM)
Net Profit
Highest at HKD 12.43 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (HKD MM)
EPS
Highest at HKD 0.02
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (HKD)
Cash and Eqv
Highest at HKD 93.39 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Here's what is not working for Fusen Pharmaceutical Co., Ltd.
Interest
Highest at HKD 13.09 MM
in the last five periods and Increased by 44.98% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (HKD MM)
Raw Material Cost
Grown by 34.51% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
